A research group at Medical University Pecs (Hungary) conducted a study to evaluate the effects of BioBran. They published a research paper titled “Can a standardized plant immunomodulator (rice bran arabinoxylan concentrate/MGN-3) increase the effects of MEK and BRAF inhibitors with clinical benefit? Case report of a patient with carcinoma in biliary duct”.

This study was published in “Research and Review Insights, Volume 1(3), 1-4, 2017”.